GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
GERON CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.20+0.03 (+2.56%)
Close on Oct 19, 2026
- Market cap
- $804.84K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
$0.00 (0.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $804.84K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.00
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$67.61M
- EPS, diluted
- -$0.10
- Book value per share
- $325.95
- Diluted shares
- 1M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$51.77M
Net income
-$67.61M
EPS, diluted
-$0.10
Free cash flow
–
Reported periodTrailing twelve months